| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 5,950,000 | 4,818,000 | 4,260,000 | 3,691,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 5,950,000 | 4,818,000 | 4,260,000 | 3,691,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,602,000 | 3,689,000 | 3,734,000 | 3,355,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,862,000 | 250,000 | 218,000 | 181,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 486,000 | 879,000 | 308,000 | 155,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 486,000 | 879,000 | 308,000 | 155,000 | | Interest Expense | 13,000 | 8,000 | 8,000 | 7,000 | | Income Before Tax | 473,000 | 871,000 | 300,000 | 148,000 | | Income Tax Expense | 160,000 | 302,000 | 103,000 | 48,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 313,000 | 569,000 | 197,000 | 100,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 313,000 | 569,000 | 197,000 | 100,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $313,000 | $569,000 | $197,000 | $100,000 |
|
2.03% Nasdaq 
Income Statement
